Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets
Clinical trial NCT07486453 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07486453
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-09
- Primary completion
- 2026-04-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.